HOME
PRODUCTS
COMPANY
CONTACT
FAQ
Research
Dictionary
Pharma
Sign Up
FREE
or
Login
Username:
Password:
Remember login
Login
Send password reminder...
Daniel Trageser Selected Research
Daniel Trageser Research Topics
Disease
5
Glioblastoma (Glioblastoma Multiforme)
01/2017 - 06/2011
4
Neoplasms (Cancer)
01/2017 - 08/2009
3
Precursor Cell Lymphoblastic Leukemia-Lymphoma (Acute Lymphoblastic Leukemia)
07/2015 - 10/2007
1
Brain Neoplasms (Brain Tumor)
08/2013
1
Melanoma (Melanoma, Malignant)
06/2013
1
Glioma (Gliomas)
06/2013
1
Carcinogenesis
01/2012
1
Philadelphia Chromosome
08/2009
1
Leukemia
10/2007
1
Lymphoma (Lymphomas)
10/2007
1
BCR-ABL Positive Chronic Myelogenous Leukemia (Chronic Myelogenous Leukemia)
10/2007
Drug/Important Bio-Agent (IBA)
3
Pharmaceutical Preparations
IBA
01/2017 - 06/2013
2
Protein-Tyrosine Kinases (Tyrosine Kinase)
IBA
06/2011 - 08/2009
2
Phosphotransferases (Kinase)
IBA
08/2009 - 10/2007
1
Drug Combinations
IBA
01/2017
1
Cytokines
IBA
07/2015
1
Biomarkers (Surrogate Marker)
IBA
08/2013
1
Temozolomide (Temodar)
FDA Link
Generic
08/2013
1
Niclosamide
FDA Link
08/2013
1
Antiviral Agents (Antivirals)
IBA
06/2013
1
Nucleic Acids
IBA
06/2013
1
Tretinoin (Retinoic Acid)
FDA Link
Generic
06/2013
1
Biological Products
IBA
01/2012
1
RNA-Binding Proteins (RNA-Binding Protein)
IBA
01/2012
1
Transcription Factors (Transcription Factor)
IBA
06/2011
1
DNA (Deoxyribonucleic Acid)
IBA
06/2011
1
Pre-B Cell Receptors
IBA
08/2009
1
src-Family Kinases
IBA
08/2009
1
nilotinib
FDA Link
10/2007
1
Imatinib Mesylate (Gleevec)
FDA Link
10/2007
1
bcr-abl Fusion Proteins
IBA
10/2007
Therapy/Procedure
2
Therapeutics
08/2013 - 10/2007
1
Drug Therapy (Chemotherapy)
08/2013